I am a medical oncologist who specializes in treating patients with gastrointestinal cancers, specifically cancers of the pancreas, bile ducts, stomach, esophagus, colon, rectum and liver. Historically, these cancer types rank high on the list of cancers with the worst prognosis. This highlights the urgent need for improvements in diagnosis and therapy.
As a clinical investigator, my research interest is to build a dynamic comprehensive program of clinical trials in the various therapy spaces of GI cancers. The cornerstone of this process is to collaborate with physician-scientists and clinical investigators in the local, national and international scenes of cancer care, ensuring we can offer new, cutting-edge agents for cancer treatment that fit our individual patient’s needs while we contribute to the global knowledge and development of cancer therapy.
In addition to my clinical work, I am an assistant professor in the Department of Internal Medicine, where I contribute as a clinical educator to the Division of Oncology, teaching and mentoring some of our junior colleagues.
I am honored to be part of the multidisciplinary oncology group here at The James. This is an institution with a traditionally strong infrastructure to support basic, translational and clinical research as an NCI-designated comprehensive cancer center, which provides the perfect environment for developing and conducting trials that bring new therapies and technologies to our patients. The collegial environment and the deep level of expertise across multiple disciplines is inspiring, and it really shows in the top-notch care we are able to provide to each and every patient.